Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Shares withheld for taxes President and CEO gave up 1,811 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 775 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Operating Officer gave up 889 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Legal Officer gave up 854 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Scientific Officer gave up 836 shares (to pay taxes)
  10. 4 Insider Changes in Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy Director bought 108,601 shares at $23.02 ($2,499,995)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Exercise or conversion Director acquired 7,605 shares (option exercise)

Page 17 of 21 · 414 filings